FDA Adverse Event Injury Summary report: N

DEPUY ASR XL FEM IMP SIZE 46

MDR report key: 3024052 · Received March 27, 2013

Report

Report Number
1818910-2013-04510
Event Type
Injury
Date Received
March 27, 2013
Date of Event
August 7, 2011
Report Date
March 24, 2015
Manufacturer
DEPUY INTERNATIONAL LTD. 8010379
Product Code
KWA
Removal / Correction Number
Z- 1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED. THE CORRECTION/REMOVAL REPORTING NUMBER LISTED APPLIES TO THE CORRESPONDING PRODUCT CODE SOLD DOMESTICALLY.

Additional Manufacturer Narrative · 1

IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.DEPUY STILL CONSIDERS THIS CASE CLOSED TO CAPA.

Description of Event or Problem · 1

ASR REVISION; ASR XL ACETABULAR SYSTEM (RIGHT); REASON(S) FOR REVISION: ALVAL / SOFT TISSUE REACTION.

Description of Event or Problem · 1

(B)(4). ASR REVISION RECOMMENDED. ASR XL ACETABULAR SYSTEM (RIGHT). UPDATE: ADDED HOSPITAL, REASON FOR REVISION AND DATE OF REVISION. RECEIVED: MARCH 19TH 2013. REASON(S) FOR REVISION: ALVAL / SOFT TISSUE REACTION. UPDATE 24 MAR 2015. ADDED TAPER SLEEVE AND UNK STEM ((B)(6) 2015). CONFIRMATION RECEIVED 02 APR 2015 NO STEM DETAILS AVAILABLE ((B)(6) 2015).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
126374 DEPUY ASR XL FEM IMP SIZE 46 HIP FEMORAL HEAD KWA DEPUY INTERNATIONAL LTD. 8010379 2295487

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention